CONSIDER A Fractional Chief Patient Officer

You're already building a Patient Enterprise™

The question isn’t whether to build a Patient Enterprise. It’s whether you are building it intentionally and fully integrated into your strategy, your science, and the value you are trying to create.

Health Advocacy Strategies helps life sciences companies envision, build and sustain Patient Enterprise. This executive capability connects the decisions that shape culture, organizational development, portfolio strategy, product development, evidence, trial and launch readiness, and enterprise value.

Two colleagues in conversation across a table, discussing strategy

Patient Enterprise is the leadership, culture, relationships, and systems that determine whether patient impact shapes a company at the enterprise level — not a single function or department.

the landscape now

Patient engagement is moving earlier.

Patient engagement is no longer a launch-stage activity. It is developed as a foundational strategic capacity to address critical moments as they arrive.

Development

Patients, caregivers, and patient organizations are shaping development

Patients, caregivers, and patient organizations now shape research priorities, inform endpoint relevance, trial feasibility and burden, support clinical trial awareness and referral, influence policy, and help patients and families navigate complex decisions.

EARNING Trust

Trust compounds over time

Trust cannot be built quickly in the moments leading up to launch. It grows through consistency, transparency, follow-through, and shared learning. When trust is built early, companies are better able to engage credibly, listen, adapt, and navigate both progress and uncertainty with the communities they serve.

Evidence

Patient experience has become part of the evidence conversation

Patient experience data, lived experience, and patient-generated insight are increasingly shaping how companies, regulators, clinicians, payers, and communities understand benefit, risk, burden, and value.

The case for building earlier

Patient enterprise built early becomes part of how a company thinks.

When shapes how the company thinks.

When engagement waits
  • Engagement waits until commercialization is in sight.
  • Direction, strategy, and evidence priorities are set before patients are in the room.
  • Teams learn to make foundational decisions without a disciplined way to understand patients.
  • Engagement becomes something the company needs — a requirement.
Patient-Centered Lifecycle Strategy
  • Experience informs the company while assumptions are still forming.
  • Systems, relationships, and operating discipline connect experience to decisions.
  • Patient focus shapes how leaders decide, how teams are hired, and how the company learns.
  • Engagement becomes culture — and culture becomes the company’s value.

Know where your Patient Enterprise stands today.

Elevate patient impact to the executive table with a Chief Patient Officer who puts it at the center of how your company decides, leads, operates, and grows.

Meet Tiffany

Enterprise leadership, built from inside the business.

I’m Tiffany Patrick, founder of Health Advocacy Strategies. I have spent more than 25 years in life sciences, working across drug development, commercialization, and enterprise value creation in oncology, rare disease, CNS, cardio-metabolic, and specialty markets.

I have worked in companies moving from early science to clinical development, from first launch to label expansion, from post-approval strategy to complex transition moments. I have seen how the influence of patients, caregivers, and advocates can strengthen development decisions, reveal in real-time flawed assumptions across the organization, shape evidence, inform access, and build the trust companies need long before and after launch.

Most recently, I served as Chief Patient Officer at Amicus Therapeutics, where I led Patient & Professional Advocacy as an enterprise function.

Health Advocacy Strategies brings that experience to life sciences companies that need Patient Enterprise leadership before they are ready, or structured, for a full-time Chief Patient Officer.

Tiffany Patrick, founder of Health Advocacy Strategies
My Areas of expertise
OncologyRare DiseaseCNS, Cardio-Metabolic & Specialty MarketsRNAi & Novel ModalitiesLifecycle StrategyPatient Enterprise ScalingAI-Enabled IntelligencePatient-Dedicated CultureOncologyRare DiseaseCNS, Cardio-Metabolic & Specialty MarketsRNAi & Novel ModalitiesLifecycle StrategyPatient Enterprise ScalingAI-Enabled IntelligencePatient-Dedicated Culture
25+ Years

Across drug development, commercialization, and value creation in oncology, rare disease, CNS, cardio-metabolic, and specialty markets.

Program Lifecycle Experience

From preclinical and clinical-stage growth to launch readiness, label expansion, post-approval strategy, and complex transition moments.

Patient Enterprise Scaling

Building the leadership systems, operating models, culture, and engagement discipline that allow patient enterprise to grow with the company.

AI-Enabled Intelligence

Using AI-enabled mapping, intelligence, and insight capture to measure, integrate, and scale patient enterprise as the organization learns.

Services

Executive leadership, matched to your stage.

Health Advocacy Strategies provides fractional Chief Patient Officer and strategic advisory support for life sciences companies building Patient Enterprise more intentionally, and at the right level of leadership.

Patient Enterprise Diagnostic

Know where Patient Enterprise stands today

A diagnostic across four dimensions: leadership, relationships, systems, culture — scalable to the priorities and stage of your company.

Patient-Centered Lifecycle Strategy

A Patient Enterprise strategy, wired into your development process

Embedding patient expertise, community leverage, and lived experience.

Patient Intelligence System

A toolset that cycles patient insight into operations, continuously

Including AI tools that elevate the advocacy landscape and patient context at scale, cycled continuously into how the company operates.

Point-in-time

A Patient Enterprise that scales as you do

Diagnostic, strategy, and toolsets working together so Patient Enterprise keeps pace as the company grows.

who it's for

For leaders building Patient Enterprise before it becomes urgent.

Founders and CEOs

Turning science into a company

You are translating a scientific vision into a company. Health Advocacy Strategies helps connect that vision to a patient enterprise model that can shape culture, development choices, external engagement, and long-term value from the beginning.

Chief Medical and development Officers

Making decisions while assumptions are still forming

You are making decisions about disease burden, endpoints, trial feasibility, evidence, and development strategy. Health Advocacy Strategies helps bring patient and caregiver experience into those decisions while assumptions are still forming.

CHIEF Commercial & Communications Leaders

Building readiness before launch pressures define the work

You are preparing for the moments when external trust, accessible communication, patient understanding, and community relationships become visible. Health Advocacy Strategies helps build readiness before launch pressures define the work.

Board Members and Investors

Assessing risk, reputation, and advantage

You are evaluating whether patient enterprise is a source of risk, reputation strength, or competitive advantage across a company or portfolio. Health Advocacy Strategies helps assess maturity, community context, and value-creation opportunity.

Chief People Officers

Building a culture that serves patients and attracts talent

You are scaling an organization and shaping a culture that connects employees to the impact of the science on patients. Health Advocacy Strategies helps HR teams translate purpose into values, goals, and accountability that inspires patient dedication, and attracts and retains exceptional talent.

Let's get started

Build Patient Enterprise before you need to retrofit it.

Most engagements begin with a focused strategy conversation about your company’s stage, science, community context, and near-term decisions.